![George Matcham](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 275 844 $ in data 30/09/2026
George Matcham is currently an Independent Director at Instil Bio, Inc. since 2018.
Formerly, Dr. Matcham was a Non-Executive Director at Chimeric Therapeutics Ltd. (Australia) from 2021 to 2023.
From 2017 to 2018, Dr. Matcham was SVP-CAR T CMC & Technology Development at Celgene Corp.
Dr. Matcham also served as Chief Operating Officer at Celgene Cellular Therapeutics.
Education includes graduate studies at the University of Cambridge and undergraduate and doctorate degrees from the University of Cardiff.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
INSTIL BIO, INC. 0,56% | 11/06/2026 | 38.100 ( 0,56% ) | 275 844 $ | 30/09/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| INSTIL BIO, INC. | Direttore/Membro del Consiglio | 01/09/2018 |
| Società | Posizione | Fine |
|---|---|---|
| CHIMERIC THERAPEUTICS LIMITED | Direttore/Membro del Consiglio | 03/08/2023 |
| CELGENE | Corporate Officer/Principal | 01/06/2018 |
Celgene Cellular Therapeutics
 Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Develops human pharmaceuticals | Direttore operativo | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cardiff
 University of Cardiff Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celgene Cellular Therapeutics
Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Develops human pharmaceuticals | Health Technology |
Instil Bio, Inc.
 Instil Bio, Inc. BiotechnologyHealth Technology Develops tumour infiltrating lymphocytes for the treatment of cancer | Health Technology |
Chimeric Therapeutics Ltd. (Australia)
 Chimeric Therapeutics Ltd. (Australia) BiotechnologyHealth Technology Develops cell therapies for the tumors | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
